Intra - Operative anesthesia management in patients undergoing surgical irreversible electroporation of the pancreas, liver, kidney, and retroperitoneal tumors

Anesthesiology and Pain Medicine

Volumn 5, Issue 3, 2015, Pages

  Martin, Robert Cg ^a,b   Schwartz, Eric ^a   Adams, Joann ^a   Farah, Ian ^a   Derhake, Brian M ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Anesthetic; Electroporation; Tumors

Indexed keywords

ESMOLOL; FENTANYL; GLYCERYL TRINITRATE; GLYCOPYRRONIUM BROMIDE; HYDRALAZINE; HYDROMORPHONE; ISOFLURANE; KETAMINE; KETOROLAC; LABETALOL; LIDOCAINE; METOPROLOL; MIDAZOLAM; NARCOTIC AGENT; NEOSTIGMINE; ONDANSETRON; PHENYLEPHRINE; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; VECURONIUM;

ABDOMINAL DRAINAGE; ABDOMINAL TUMOR; ABLATION THERAPY; ANESTHESIA; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; EPIDURAL ANESTHESIA; HEART RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; IRREVERSIBLE ELECTROPORATION THERAPY; KIDNEY TUMOR; LAPAROSCOPY; LENGTH OF STAY; LIVER TUMOR; METASTASIS; MUSCLE EXCITATION; NEUROMUSCULAR BLOCKING; OUTCOME ASSESSMENT; PANCREAS TUMOR; POSTOPERATIVE CARE; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 84930989098     PISSN: 22287523     EISSN: 22287531     Source Type: Journal    
DOI: 10.5812/aapm.22786     Document Type: Article

References (11)

1. Martin II RCG, McFarland K, Ellis S, Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol. 2013;20(3):443–9.
2. Cannon R, Ellis S, Hayes D, Narayanan G, Martin R2. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol. 2013;107(5):544–9.
3. Ball C, Thomson KR, Kavnoudias H. Irreversible electroporation: a new challenge in "out of operating theater" anesthesia. Anesth Analg. 2010;110(5):1305–9.
4. Dunki-Jacobs EM, Philips P, Martin R2. Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas. J Am Coll Surg. 2014;218(2):179–87.
5. Martin RCG. Irreversible Electroporation of Locally Advanced Pancreatic Head Adenocarcinoma. J Gastrointest Surg. 2013;17(10):1850–6.
6. Martin RCG. Irreversible Electroporation: a Novel Option for Treatment of Hepatic Metastases. Curr Colorectal Cancer Rep. 2013;9(2):191–7.
7. Philips P, Hays D, Martin RC. Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated. PLoS One. 2013;8(11).
8. Trabold B, Wiggermann P, Akyol D, Jung EM, Niessen C, Stroszczynski C, et al. Anesthesia for irreversible electroporation of hepatic malignant tumors. J Clin Anesth. 2013;25(5):430–1.
9. Imantalab V, Seddighi Nejad A, Mir Mansouri A, Sadeghi Meibodi A, Haghighi M, Dadkhah H, et al. A comparative study of cardioprotective effect of three anesthetic agents by measuring serum level of troponin-T after coronary artery bypass grafting. Int Cardiovasc Res J. 2012;6(3):70–4.
10. Dunki-Jacobs EM, Philips P, Scoggins CR, McMasters KM, Martin R2. Stroke volume variation in hepatic resection: a replacement for standard central venous pressure monitoring. Ann Surg Oncol. 2014;21(2):473–8.
11. Martin R, McFarland K, Ellis S, Velanovich V. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. J Am Coll Surg. 2012;215(3):361–9.